Paper17568013
Mixed brain pathologies account for most dementia cases in community-dwelling older persons.
Schneider JA and 3 others. Neurology, 2007. Cited by 1,516 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Papers, record 17568013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17568013
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mixed brain pathologies account for most dementia cases in community-dwelling older persons.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Dementia | Major topic |
| Housing for the Elderly | Major topic |
| Aged, 80 and over | |
| Cohort Studies | |
| Female | |
| Humans | |
| Long-Term Care | |
| Longitudinal Studies | |
| Male |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG015819 | NIA NIH HHS | United States | R01AG015819 | PubMed and NIH | NIH RePORTER |
| P30 AG10161 | NIA NIH HHS | United States | P30AG010161 | PubMed and NIH | NIH RePORTER |
| R01 AG15819 | NIA NIH HHS | United States | R01AG015819 | PubMed and NIH | NIH RePORTER |
| K08 AG00849 | NIA NIH HHS | United States | K08AG000849 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03507257 | Longitudinal Early-onset Alzheimer's Disease Study Protocol | Background | ClinicalTrials.gov | |
| NCT06836141 | Biomarkers for Cognitive Decline in Intracerebral Hemorrhage | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 18,071,139 | Dementia: many roads, but not built in a day. | https://conductscience.org/library/papers/18071139 | PubMed |
| Comment in | 18,316,696 | Mixed brain pathologies account for most dementia cases in community-dwelling older persons. | https://conductscience.org/library/papers/18316696 | PubMed |
Cited by1,083
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,516 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,958,434 | Neuropathological and vascular determinants of cerebral amyloid angiopathy risk: evidence from the NACC cohort. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42958434 | PubMed |
| 42,948,654 | Exercise and white matter hyperintensities: a randomized clinical trial. | Brain Commun | 2026 | https://conductscience.org/library/papers/42948654 | PubMed |
| 42,928,437 | Neuropathologic features of cognitively defined Alzheimer's disease subgroups in the Adult Changes in Thought study. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42928437 | PubMed |
| 42,883,821 | Plasma Neurofilament Light Chain as a Complementary Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883821 | PubMed |
| 42,845,623 | Digital quantification of vascular β-amyloid and perivascular plaques in cerebral amyloid angiopathy. | Res Sq | 2026 | https://conductscience.org/library/papers/42845623 | PubMed |
| 42,840,267 | Association of mild cognitive impairment and comorbid depression with postoperative delirium in patients undergoing knee/hip arthroplasty: a prospective cohort study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42840267 | PubMed |
| 42,833,623 | Physical Performance Moderates the Association Between Age and Executive Function in Older Adults at Elevated Risk of Dementia: Cross-Sectional Analysis From the CITA GO-ON Trial. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/42833623 | PubMed |
| 42,828,695 | Multimodal neuroimaging in dementia and neurodegenerative disorders: complementary roles of clinically available nuclear medicine and MRI in the era of disease-modifying therapies. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/42828695 | PubMed |
| 42,810,101 | Resting-state functional and spectral alterations underlying cognitive decline in biomarker-confirmed Alzheimer's disease: A systematic review. | Neuroimage Clin | 2026 | https://conductscience.org/library/papers/42810101 | PubMed |
| 42,806,367 | Fecal Aβ and tau aggregates are elevated in cognitive impairment and reveal peripheral proteopathic alterations. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42806367 | PubMed |
| 42,798,633 | Explanatory limitations of CSF, plasma, and MRI biomarkers for inflammation and blood-brain barrier disruption in dementia. | Front Aging | 2026 | https://conductscience.org/library/papers/42798633 | PubMed |
| 42,793,080 | Decreased Plasma IGF-1 Is Associated with Cortical Atrophy, but Not Concomitant Cerebrovascular Disease in Alzheimer's Dementia. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793080 | PubMed |
| 42,779,634 | Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779634 | PubMed |
| 42,743,907 | Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features. | J Prev Alzheimers Dis | 2026 | https://conductscience.org/library/papers/42743907 | PubMed |
| 42,742,642 | A new era of genome-wide association studies in the field of Alzheimer's disease and overlapping co-pathologies: lessons learned from a neuropathology-centered approach. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42742642 | PubMed |
| 42,741,835 | Early Life Vascular Risk and Midlife Markers of Brain Aging. | Stroke | 2026 | https://conductscience.org/library/papers/42741835 | PubMed |
| 42,733,037 | Cerebral oxygen extraction fraction as a physiological biomarker in vascular cognitive impairment: A study in older adults enriched for small vessel diseases. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42733037 | PubMed |
| 42,719,047 | Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42719047 | PubMed |
| 42,676,530 | From pathology to network failure: a Question-Model-Outcome framework for interpreting animal models of AD-related and dementia-relevant mechanisms. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42676530 | PubMed |
| 42,653,355 | Cerebral Intramural Cells: A Missing Cellular Link Between Vascular Aging and Alzheimer's Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653355 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17568013
GET https://conductscience.org/api/papers/v1/17568013/cited_by?page=2